Nordea Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.65M | Buy |
|
|||||
|
2025
Q2 | $3.64M | Buy |
|
|||||
|
2025
Q1 | $2.71M | Buy |
|
|||||
|
2024
Q4 | $2.42M | Buy |
|
|||||
|
2024
Q3 | $2.63M | Buy |
|
|||||
|
2024
Q2 | $2.31M | Buy |
|
|||||
|
2024
Q1 | $1.37M | Buy |
|
|||||
|
2023
Q4 | $1.67M | Hold |
|
|||||
|
2023
Q3 | $1.53M | Buy |
|
|||||
|
2023
Q2 | $1.65M | Sell |
|
|||||
|
2023
Q1 | $1.71M | Buy |
|
|||||
|
2022
Q4 | $2.02M | Buy |
|
|||||
|
2022
Q3 | $1.57M | Buy |
|
|||||
|
2022
Q2 | $1.03M | Buy |
|
|||||
|
2022
Q1 | $1.15M | Sell |
|
|||||
|
2021
Q4 | $1.25M | Buy |
|
|||||
|
2021
Q3 | $946K | Hold |
|
|||||
|
2021
Q2 | $873K | Hold |
|
|||||
|
2021
Q1 | $725K | Sell |
|
|||||
|
2020
Q4 | $705K | Hold |
|
|||||
|
2020
Q3 | $782K | Sell |
|
|||||
|
2020
Q2 | $1.61M | Buy |
|
|||||
|
2020
Q1 | $523K | Hold |
|
|||||
|
2019
Q4 | $549K | Buy |
|
|||||
|
2019
Q3 | $281K | Buy |
|
|||||
|
2019
Q2 | $217K | Hold |
|
|||||
|
2019
Q1 | $279K | Hold |
|
|||||
|
2018
Q4 | $218K | Hold |
|
|||||
|
2018
Q3 | $261K | Hold |
|
|||||
|
2018
Q2 | $294K | Hold |
|
|||||
|
2018
Q1 | $356K | Hold |
|
|||||
|
2017
Q4 | $379K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $143K | Hold |
|
|||||
|
2016
Q2 | $117K | Hold |
|
|||||
|
2016
Q1 | $132K | Buy |
|
|||||
|
2015
Q4 | $181K | Hold |
|
|||||
|
2015
Q3 | $154K | Hold |
|
|||||
|
2015
Q2 | $230K | Buy |
|